• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Tivic Health Systems Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket

    7/10/23 8:11:41 AM ET
    $ADES
    $AGLE
    $ALPP
    $AXLA
    Major Chemicals
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADES alert in real time by email

    Gainers

    • Nanobiotix S.A. (NASDAQ:NBTX) shares surged 59.3% to $8.02 in pre-market trading after the company entered into a license agreement with Janssen Pharmaceutical for global co-development and commercialization of NBTXR3.
    • Alpine 4 Holdings, Inc. (NASDAQ:ALPP) shares gained 29.2% to $2.17 in pre-market trading after the company said its subsidiary, Vayu Aerospace Corporation, received its first $5.25m purchase order from its $100 million supply agreement with U.S. Government contractor, All American Contracting, Inc..
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares rose 23.4% to $0.1419 in pre-market trading after gaining over 38% on Friday.
    • Trinity Place Holdings Inc. (NYSE:TPHS) gained 16.5% to $0.7461 in pre-market trading after climbing 23% on Friday.
    • Axcella Health Inc. (NASDAQ:AXLA) rose 14.7% to $0.2452 in pre-market trading.
    • AIM ImmunoTech Inc. (NYSE:AIM) shares rose 14.6% to $0.7535 in pre-market trading after gaining 6% on Friday.
    • Siyata Mobile Inc. (NASDAQ:SYTA) shares climbed 14.2% to $0.0708 in pre-market trading after gaining around 12% on Friday.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) rose 13.5% to $0.1789 in pre-market trading. SMX recently priced a $3.2 million public offering.
    • Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) gained 13.5% to $1.25 in pre-market trading after declining around 7% on Friday.
    • urban-gro, Inc. (NASDAQ:UGRO) shares gained 13.2% to $2.15 in pre-market trading after jumping over 29% on Friday.

    Losers

    • Neonode Inc. (NASDAQ:NEON) fell 30.4% to $5.10 in pre-market after dropping over 8% on Friday.
    • Tivic Health Systems, Inc. (NASDAQ:TIVC) fell 23.3% to $0.0850 in pre-market trading after the company reported a proposed public offering of common stock.
    • Femasys Inc. (NASDAQ:FEMY) fell 12.5% to $0.45 in pre-market trading.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) fell 9.8% to $0.46 in pre-market trading after climbing 8% on Friday.
    • Nayax Ltd. (NASDAQ:NYAX) fell 9.6% to $18.85 in pre-market trading.
    • Advanced Emissions Solutions, Inc. (NASDAQ:ADES) fell 8.7% to $1.55 in pre-market trading after gaining 3% on Friday.
    • INVO Bioscience, Inc. (NASDAQ:INVO) shares dropped 7.8% to $0.1745 in pre-market trading after gaining 5% on Friday.
    • Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) fell 7.3% to $0.4451 in pre-market trading after declining around 8% on Friday.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) shares fell 6.9% to $1.75 in pre-market trading after climbing around 57% on Friday.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) shares dropped 5.7% to $0.1518 in pre-market trading.

     

    Now Read This: Investor Sentiment Declines Following Jobs Data

    Get the next $ADES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADES
    $AGLE
    $ALPP
    $AXLA

    CompanyDatePrice TargetRatingAnalyst
    Nanobiotix S.A.
    $NBTX
    2/6/2026Buy
    TD Cowen
    Femasys Inc.
    $FEMY
    11/20/2025$6.50Buy
    Laidlaw
    Neonode Inc.
    $NEON
    9/4/2025$6.00Buy → Neutral
    Ladenburg Thalmann
    Nayax Ltd.
    $NYAX
    4/1/2025Mkt Perform → Outperform
    William Blair
    Nayax Ltd.
    $NYAX
    11/19/2024$38.00Buy
    B. Riley Securities
    Neonode Inc.
    $NEON
    10/18/2024$16.50Buy
    Ladenburg Thalmann
    Nayax Ltd.
    $NYAX
    10/1/2024Perform
    Oppenheimer
    Nanobiotix S.A.
    $NBTX
    8/28/2024$12.00Buy
    Guggenheim
    More analyst ratings

    $ADES
    $AGLE
    $ALPP
    $AXLA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kellner Ted D bought $50,000 worth of shares (1,968,504 units at $0.03), increasing direct ownership by 196,850% to 1,969,504 units (SEC Form 4)

    4 - AIM ImmunoTech Inc. (0000946644) (Issuer)

    4/23/25 4:35:16 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Mitchell William M bought $5,000 worth of shares (196,851 units at $0.03), increasing direct ownership by 61% to 521,723 units (SEC Form 4)

    4 - AIM ImmunoTech Inc. (0000946644) (Issuer)

    4/23/25 4:35:19 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CEO & President Equels Thomas K bought $50,000 worth of shares (1,968,504 units at $0.03), increasing direct ownership by 104% to 3,867,533 units (SEC Form 4)

    4 - AIM ImmunoTech Inc. (0000946644) (Issuer)

    4/23/25 4:35:17 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADES
    $AGLE
    $ALPP
    $AXLA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Manor Sagit

    4 - Nayax Ltd. (0001901279) (Issuer)

    4/23/26 9:37:17 AM ET
    $NYAX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Greenberg Aaron Samuel

    4 - Nayax Ltd. (0001901279) (Issuer)

    4/23/26 9:25:26 AM ET
    $NYAX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Bolton Sheryle

    4 - Tivic Health Systems, Inc. (0001787740) (Issuer)

    4/20/26 4:02:04 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ADES
    $AGLE
    $ALPP
    $AXLA
    SEC Filings

    View All

    Mobile Global Esports Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Mobile Global Esports, Inc. (0001886362) (Filer)

    4/23/26 9:23:24 PM ET
    $MGAM
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Tivic Health Systems Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Tivic Health Systems, Inc. (0001787740) (Filer)

    4/23/26 4:36:54 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 6-K filed by Nayax Ltd.

    6-K - Nayax Ltd. (0001901279) (Filer)

    4/23/26 4:10:51 PM ET
    $NYAX
    Computer Software: Prepackaged Software
    Technology

    $ADES
    $AGLE
    $ALPP
    $AXLA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on Nanobiotix

    TD Cowen initiated coverage of Nanobiotix with a rating of Buy

    2/6/26 8:11:18 AM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Laidlaw initiated coverage on Femasys with a new price target

    Laidlaw initiated coverage of Femasys with a rating of Buy and set a new price target of $6.50

    11/20/25 8:06:38 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    Neonode downgraded by Ladenburg Thalmann with a new price target

    Ladenburg Thalmann downgraded Neonode from Buy to Neutral and set a new price target of $6.00

    9/4/25 8:03:55 AM ET
    $NEON
    Industrial Machinery/Components
    Technology

    $ADES
    $AGLE
    $ALPP
    $AXLA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model

    Ticker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod™ Toward BARDA Funding and Strategic National Stockpile Procurement While Velocity Bioworks CDMO Builds Independent Revenue BaseSAN ANTONIO, April 23, 2026 /PRNewswire/ -- Tivic Health Systems, Inc. (NASDAQ:TIVC) today announced it is changing its corporate name to Valion Bio, Inc. and its Nasdaq ticker symbol from TIVC to VBIO, effective at market open on Tuesday, April 28, 2026. The CUSIP number for the company's common stock will remain unchanged. The rebrand is not merely cosmetic.

    4/23/26 4:05:00 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    urban-gro, Inc. (Nasdaq: UGRO) — Sri Lanka Cricket Confirms July 10 – August 5, 2026 and Four Venues for Lanka Premier League Season 6; Tournament Conducted in Partnership with UGRO Subsidiary IPG Group

    LAFAYETTE, Colo., April 23, 2026 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), operating through Flash Sports & Media, Inc., today noted the official announcement by Sri Lanka Cricket ("SLC") confirming the dates, venues, and player-registration timeline for Lanka Premier League ("LPL") Season 6. The tournament will run from July 10 to August 5, 2026, and is owned by SLC and conducted in partnership with Innovative Production Group FZ, LLC ("IPG"), the event rights holder. The Company participates in the tournament through its subsidiary, IPG under existing commercial arrangements. Season 6 — By the Numbers Tournament windowJuly 10 – August 5, 2026 (

    4/23/26 7:05:00 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

    ATLANTA, April 22, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the commercial launch of FemaSeed Complete, a comprehensive fertility solution that enables OB/GYNs to perform first-line insemination entirely within their own practices. An estimated 10 million women in the United States experience infertility, yet fewer than half access care, and only a very small percentage ultimately undergo IVF. At the same time, U.S. fertility rates declined again in 2025 to a record low, underscoring the growing need for ear

    4/22/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    $ADES
    $AGLE
    $ALPP
    $AXLA
    Leadership Updates

    Live Leadership Updates

    View All

    urban-gro, Inc. (Nasdaq: UGRO) — Sri Lanka Cricket Confirms July 10 – August 5, 2026 and Four Venues for Lanka Premier League Season 6; Tournament Conducted in Partnership with UGRO Subsidiary IPG Group

    LAFAYETTE, Colo., April 23, 2026 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), operating through Flash Sports & Media, Inc., today noted the official announcement by Sri Lanka Cricket ("SLC") confirming the dates, venues, and player-registration timeline for Lanka Premier League ("LPL") Season 6. The tournament will run from July 10 to August 5, 2026, and is owned by SLC and conducted in partnership with Innovative Production Group FZ, LLC ("IPG"), the event rights holder. The Company participates in the tournament through its subsidiary, IPG under existing commercial arrangements. Season 6 — By the Numbers Tournament windowJuly 10 – August 5, 2026 (

    4/23/26 7:05:00 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    urban-gro, Inc. (Nasdaq: UGRO) Announces Lanka Premier League Season 6 — Potential Record 600-Player Pool, World-Class Marquee Talent, and Expected Appointment of Chris Gayle as Global Brand Ambassador

    LAFAYETTE, Colo., April 13, 2026 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), operating through Flash Sports & Media, Inc., a vertically integrated sports, media, and experiential platform, today announced that Lanka Premier League ("LPL") Season 6 — executed via its subsidiary Innovative Production Group FZ, LLC ("IPG") platform — is expecting record-breaking expansion. Season 6 is projected to feature the largest-ever LPL player registration pool of 500 to 600 athletes expected to be drawn from the world's top cricketing nations, elevated by a marquee roster of global superstars and the expected appointment of T20 legend Chris Gayle as official Brand

    4/13/26 7:05:00 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

    ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the appointment of John Canning as Chief Operating Officer. Mr. Canning is an accomplished medical device executive with more than 25 years of experience leading global operations and technology organizations within complex medical device companies. He brings a track record of scaling organizations, advancing product pipelines, and driving operational excellence across key functions to support commercial growth and product adoption. Prior to joining

    4/1/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    $ADES
    $AGLE
    $ALPP
    $AXLA
    Financials

    Live finance-specific insights

    View All

    NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results

    Global development program for JNJ-1900 (NBTXR3) proceeded as planned, building toward opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck cancer and lung cancerClinical results reported across multiple tumor types including esophageal cancer, pancreatic cancer, melanoma, head and neck cancer, and lung cancer that supported the broad potential of JNJ-1900 (NBTXR3) across solid tumors treated with radiotherapy next to the completion of the transfer of sponsorship for NANORAY-312Strengthened financial position through the closing of a non-dilutive royalty financing with HealthCare Royalty for up to $71 million and an amendment to the gl

    3/31/26 4:15:00 PM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

    ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the year ended December 31, 2025 and provides a corporate update. Corporate Highlights from 4Q 2025 to date Initiated patient enrollment in the FINALE pivotal clinical trial evaluating FemBloc, advancing toward U.S. approval.Appointed Kenneth D. Eichenbaum, M.D., M.S.E., to the Board of Directors, strengthening leadership and strategic oversight.FemBloc permanent birth control system achieved certification under the Medical Device Single Au

    3/31/26 4:05:00 PM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026

    PARIS and CAMBRIDGE, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ:NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, March 31st, 2026, after the close of the U.S. market. This release will be followed by a conference call and webcast on Wednesday, April 1st, 2026, at 8:00 AM EDT / 2:00 PM CEST, prior to the open of the U.S. market. During the call, Laurent Levy, chief executive office

    3/26/26 4:15:00 PM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADES
    $AGLE
    $ALPP
    $AXLA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by AIM ImmunoTech Inc.

    SC 13D/A - AIM ImmunoTech Inc. (0000946644) (Subject)

    12/17/24 4:11:23 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Siyata Mobile Inc.

    SC 13G/A - Siyata Mobile Inc. (0001649009) (Subject)

    11/14/24 7:28:44 PM ET
    $SYTA
    Telecommunications Equipment
    Telecommunications

    SEC Form SC 13G filed by T2 Biosystems Inc.

    SC 13G - T2 Biosystems, Inc. (0001492674) (Subject)

    11/14/24 3:38:45 PM ET
    $TTOO
    Medical/Dental Instruments
    Health Care

    $ADES
    $AGLE
    $ALPP
    $AXLA
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary